Blurbs

Analysts Offer Insights on Healthcare Companies: Masimo (MASI), Marinus (MRNS) and Siemens Healthineers AG (OtherSEMHF)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Masimo (MASIResearch Report), Marinus (MRNSResearch Report) and Siemens Healthineers AG (SEMHFResearch Report) with bullish sentiments.

Masimo (MASI)

In a report released today, Michael Matson from Needham reiterated a Buy rating on Masimo, with a price target of $149.00. The company’s shares closed last Tuesday at $123.07, close to its 52-week low of $112.07.

According to TipRanks.com, Matson is a 1-star analyst with an average return of -1.3% and a 43.6% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Cardiovascular Systems.

Currently, the analyst consensus on Masimo is a Moderate Buy with an average price target of $167.83.

See Insiders’ Hot Stocks on TipRanks >>

Marinus (MRNS)

Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on Marinus today and set a price target of $17.00. The company’s shares closed last Tuesday at $4.65, close to its 52-week low of $3.97.

According to TipRanks.com, Higgins is a 3-star analyst with an average return of 2.9% and a 28.6% success rate. Higgins covers the Healthcare sector, focusing on stocks such as Eiger Biopharmaceuticals, Zynerba Pharmaceuticals, and Armata Pharmaceuticals.

Marinus has an analyst consensus of Strong Buy, with a price target consensus of $23.40, representing a 408.7% upside. In a report released today, Robert W. Baird also maintained a Buy rating on the stock with a $24.00 price target.

Siemens Healthineers AG (SEMHF)

In a report released today, Graham Doyle from UBS maintained a Buy rating on Siemens Healthineers AG, with a price target of EUR56.00. The company’s shares closed last Monday at $46.94.

According to TipRanks.com, Doyle is ranked #7173 out of 8037 analysts.

Currently, the analyst consensus on Siemens Healthineers AG is a Strong Buy with an average price target of $59.26, which is a 26.1% upside from current levels. In a report issued on October 27, Kepler Capital also maintained a Buy rating on the stock with a EUR55.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MASI:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More